Search results
-
Capturing Confectionery (D) (Spanish version)
Collis, David J.; Stuart, Toby; Smith, TroyCase HBS-708S48StrategyIn late 2002, global confectionery and beverage maker Cadbury Schweppes needed to decide whether or not to make an acquisition bid for Adams, an underperforming gum company which had been put up for sale by pharmaceutical giant Pfizer. Examining the decision from a strategic perspective, the (A) case provides brief histories of the two companies; traces the global confectionery industry, focusing especially on chocolate and gum; and details the a...Starting at €5.74
-
Cooper Industries' Corporate Strategy (A) (Spanish version)
Collis, David J.; Stuart, TobyCase HBS-306S08StrategyDescribes the development of a successful corporate strategy based on the acquisition and subsequent consolidation of low-technology manufacturing companies. Starting with a company history and discussion of current business segments, the case goes on to detail the innovation of corporate headquarters in strategy formulation and operations. Highlights the synergistic possibilities in alike acquisitions and addresses the issue of long-term value c...Starting at €8.20
-
Guerra en el sector de la alimentación de animales domésticos (B)
Collis, David J.; Stuart, TobyCase HBS-312S04StrategyDescribe el concurso para la adquisición de Anderson Clayton como actores de la industria compiten por uno de los siete principales fabricantes de alimentos para perros.Starting at €5.74
-
Guerra en el sector de la alimentación de animales domésticos (C)
Collis, David J.; Stuart, TobyCase HBS-312S05StrategyDescribe acontecimientos importantes en la industria de alimentos para mascotas en 1987 y 1988, centrándose en las interacciones competitivas entre los principales actores de la industria.Starting at €5.74
-
Bet on One Big Idea--or Diversify? (HBR Case Study and Commentary)
Stuart, TobyArticle HBS-R1311M-EStrategyA unique probiotic formulation, L-39, has great promise as a pharmaceutical treatment for a common illness. When it hits a stumbling block in its latest clinical trial, Hilde Dach, the scientist leading the research at German drug maker Caliska, faces the prospect that the company may want to reimagine her product as a nutraceutical, because the regulatory hurdles would be easier to clear. Is the company merely hedging its bets to avoid big losse...Starting at €8.20
-
Stretch the Mission (HBR Case Study)
Sahlman, William A.; Nanda, RamanaArticle HBS-R1505X-EThe founder of a nonprofit that supports emerging-market entrepreneurs must decide whether she should bring her program to the United States. Expert commentary comes from Linda Rottenberg, CEO of Endeavor Global, and Gururaj Deshpande, cofounder of the Deshpande Foundation. For teaching purposes, this is the case-only version of the HBR case study. The commentary-only version is reprint R1505Z. The complete case study and commentary is reprint R...Starting at €8.20
-
Is a Start-Up's Strength Becoming Its Weakness? (HBR Case Study and Commentary)
Nanda, Ramana; Kind, LizArticle HBS-R1511K-EStrategyThe creators of the start-up AndFound, an online platform that connects angel investors with a curated selection of promising start-ups, have a towering advantage over similar business accelerators: The site is free. But this central tenet of the company's mission presents problems as the company looks ahead and considers options for a long-range business model to monetize its services. Expert commentary comes from Kevin Laws, COO of AngelList, a...Starting at €8.20
-
Is a Start-Up's Strength Becoming Its Weakness (Commentary for HBR Case Study)
Nanda, Ramana; Kind, LizArticle HBS-R1511Z-EStrategyThe creators of the start-up AndFound, an online platform that connects angel investors with a curated selection of promising start-ups, have a towering advantage over similar business accelerators: The site is free. But this central tenet of the company's mission presents problems as the company looks ahead and considers options for a long-range business model to monetize its services. Expert commentary comes from Kevin Laws, COO of AngelList, a...Starting at €8.20
-
Cadbury Schweppes: Capturing Confectionery (D)
Collis, David J.; Stuart, Toby; Smith, TroyCase HBS-708491-EStrategyIn late 2002, global confectionery and beverage maker Cadbury Schweppes needed to decide whether or not to make an acquisition bid for Adams, an underperforming gum company which had been put up for sale by pharmaceutical giant Pfizer. Examining the decision from a strategic perspective, the (A) case provides brief histories of the two companies; traces the global confectionery industry, focusing especially on chocolate and gum; and details the a...Starting at €5.74
-
Impact Investment, Catalytic Capital and Blended Finance
Khanna, Tarun; Nanda, Ramana; Roth, Benjamin N.; Trelstad, BrianCase HBS-321078-EKnowledge and CommunicationStarting at €8.20